Surging Cases of Cancer to Drive Growth of the Global Radiodermatitis Market: TMR
Share this article Share this article ALBANY, N.Y., Jan. 25, 2021 /PRNewswire/ -- Radiodermatitis, also known as radiation dermatitis, refers to a cutaneous reaction that is caused during or after radiotherapy given to a cancer patient. A surge in the incidences of cancer worldwide is estimated to drive the growth of global radiodermatitis market over the forecast timeframe, from 2019 to 2027. In most of the cancer patients, this condition occurs at either during the process or at the initial step of radiotherapy. Various symptoms, such as skin rash, pigmentation, flaking, lesions, and dry p...
Source: prnewswire.com